Biotech SF: Santen

Showing posts with label Santen. Show all posts

Friday, April 15, 2011

Eye treatments company Santen takes 50,000 square feet in Emeryville

Santen Pharmaceutical Co., a company that makes eye medications and treatments, plans to move its U.S. headquarters to Emeryville in July.
The company, a subsidiary of Osaka, Japan-based Santen Inc., leased 50,000 square feet on the top two floors of 2100 Powell, a Class A Hines-owned building known as Watergate Tower IV.
Santen previously had an office in Napa, but executives want to be closer to the East Bay’s biotech cluster and international transportation.

Subscribe to: Comments (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.